Filed: 11/4/2025ACC: 0001193125-25-263831
📋 What this filing means
SANOFI filed this quarterly 13F‑HR report disclosing 9 equity positions with a total reported market value of $260.36M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
9
Positions
$260.36M
Total AUM (reported)
27.27M
Total Shares
Allocation by class
COM$178.75M68.7%
COM NEW$59.65M22.9%
CLASS A COM$18.96M7.3%
SHS$2.99M1.2%
Portfolio Concentration
Top 3$199.04M76.4%
4–10$61.32M23.6%
Top 3 weight
76.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 27.27M
Sole
Full voting authority
27.27M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole9
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings9
Rows:
MeiraGTx Holdings plc
SOLEShares12.20M
TypeSH
Market value$100.39M
38.56%
Sole
12.20M
Shared
0.00
None
0.00
Novavax
SOLEShares6.88M
TypeSH
Market value$59.65M
22.91%
Sole
6.88M
Shared
0.00
None
0.00
Inhibrx Biosciences, Inc.
SOLEShares1.16M
TypeSH
Market value$39.00M
14.98%
Sole
1.16M
Shared
0.00
None
0.00
AnaptysBio
SOLEShares821.92K
TypeSH
Market value$25.17M
9.67%
Sole
821.92K
Shared
0.00
None
0.00
Immuneering Corp
SOLEShares2.71M
TypeSH
Market value$18.96M
7.28%
Sole
2.71M
Shared
0.00
None
0.00
Omada Health Inc.
SOLEShares524.90K
TypeSH
Market value$11.61M
4.46%
Sole
524.90K
Shared
0.00
None
0.00
LAVA Therapeutics N.V.
SOLEShares1.92M
TypeSH
Market value$2.99M
1.15%
Sole
1.92M
Shared
0.00
None
0.00
Eledon
SOLEShares814.98K
TypeSH
Market value$2.11M
0.81%
Sole
814.98K
Shared
0.00
None
0.00
Q32 Bio Inc.
SOLEShares244.08K
TypeSH
Market value$483.3K
0.19%
Sole
244.08K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MeiraGTx Holdings plcSOLE | COM | 12.20M | SH | $100.39M 38.56% | 12.20M | 0.00 | 0.00 |
NovavaxSOLE | COM NEW | 6.88M | SH | $59.65M 22.91% | 6.88M | 0.00 | 0.00 |
Inhibrx Biosciences, Inc.SOLE | COM | 1.16M | SH | $39.00M 14.98% | 1.16M | 0.00 | 0.00 |
AnaptysBioSOLE | COM | 821.92K | SH | $25.17M 9.67% | 821.92K | 0.00 | 0.00 |
Immuneering CorpSOLE | CLASS A COM | 2.71M | SH | $18.96M 7.28% | 2.71M | 0.00 | 0.00 |
Omada Health Inc.SOLE | COM | 524.90K | SH | $11.61M 4.46% | 524.90K | 0.00 | 0.00 |
LAVA Therapeutics N.V.SOLE | SHS | 1.92M | SH | $2.99M 1.15% | 1.92M | 0.00 | 0.00 |
EledonSOLE | COM | 814.98K | SH | $2.11M 0.81% | 814.98K | 0.00 | 0.00 |
Q32 Bio Inc.SOLE | COM | 244.08K | SH | $483.3K 0.19% | 244.08K | 0.00 | 0.00 |